Skip to content
The Policy VaultThe Policy Vault

rivaroxaban oral suspensionMedica

Deep vein thrombosis or pulmonary embolism, treatment

Initial criteria

  • If Xarelto tablets requested: approve
  • If rivaroxaban oral suspension requested: patient is unable to have Xarelto tablets appropriately administered OR prescribed dose cannot be achieved by Xarelto 10 mg, 15 mg, or 20 mg tablets

Approval duration

1 year